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In both the developing and industrialized
worlds, a number of zoonoses have emerged either
as new pathologic entities or as already known
agents, appearing in areas or species in which
they had not been previously reported. In addition
known zoonotic agents have reemerged sometimes
after many years of absence in areas where they
had been reported before. In this connection,
limited and sometimes important outbreaks of
otherwise endemic zoonoses such as rabies, brucel-
losis, leptospirosis, anthrax, a number of  zoonotic
foodborne diseases (caused by Salmonella enteri-
tidis, Salmonella typhimurium, and Escherichia
coli) and arbovirus infections involving production
animals (Venezuelan equine encephalitis, Congo-
Crimean hemorrhagic fever ) have continued to
appear in many industrialized and developing
countries. Some examples of both emerging and
reemerging zoonotic infections are given below.
Emerging Zoonoses
S. typhimurium in the United Kingdom
Multidrug-resistant S. typhimurium DT 104
initially emerged in cattle in 1988 in England and
Wales. Subsequently, the strain has been isolated
from poultry, sheep, pigs, and horses. Anti-
microbial therapy is used extensively to combat
S. typhimurium infection in animals. The
evolution of a strain resistant to the commonly
used antibiotics has made infections with
S. typhimurium DT 104 in food animals difficult
to control and likely to remain a zoonotic
problem. Furthermore, in S. typhimurium DT
104 of R-type ACSSuT, multiple-drug resistance
has become an integral part of the genetic material
of the organism. Unlike other salmonella
serotypes, multidrug-resistant S. typhimurium
DT 104 is, therefore, likely to retain its resistance
genes even when antimicrobial drugs are no longer
used. Unlike S. enteritidis, which is mainly
associated with poultry and eggs, multidrug-
resistant S. typhimurium DT 104 can be found in
a broad range of foods. Outbreaks in the United
Kingdom have been linked to poultry, various
meats and meat products, and unpasteurized
milk. In addition to infections from contaminated
food, cases have also occurred from human con-
tact with infected cattle. A small proportion of
cases may have been caused by pets such as cats
and dogs, which can also be infected with this
strain of  Salmonella. Like humans, pets probably
acquire the infection through consumption of con-
taminated raw meat, poultry, or poultry-derived
products. The emergence of Salmonella strains
resistant to antibiotics in common use is impor-
tant to clinicians, microbiologists, and those respon-
sible for the control of communicable disease.
Global Aspects of Emerging and Potential
Zoonoses: a WHO Perspective
Many new human pathogens that have emerged or reemerged worldwide
originated from animals or from products of animal origin. Many animal species as well
as categories of agents have been involved in the emergence of diseases. Wild (e.g.,
bats, rodents) as well as draught animals (e.g., horses) and food animals ( e.g., poultry,
cattle) were implicated in the epidemiologic cycles of these diseases. Many of the agents
responsible for new infections and diseases in humans were viruses (e.g., hantaviruses,
lyssaviruses, and morbilliviruses), but bacteria, especially enteritic bacteria (e.g.,
Salmonellae and Escherichia coli) and parasites (e.g., Cryptosporidium) of animal
origin, were also involved in major food and waterborne outbreaks. The public health
relevance of some of these agents (e.g., new lyssaviruses and morbilliviruses) is not yet
fully assessed. In addition the zoonotic nature of some other human diseases, such as
Ebola and the new variant form of Creutzfeldt-Jakob disease, is suspected but not yet
demonstrated. Finally, the possible future use of xenografts may lead, if precautions are
not taken, to the emergence of new diseases called xenozoonoses.224 Emerging Infectious Diseases Vol. 3, No. 2, April–June 1997
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Equine Morbillivirus in Australia
Equine morbillivirus (EMV) was isolated in
September 1994 in Queensland, Australia.
Fourteen horses died as a result of infection with
EMV in southeast Queensland during September
1994. Seven additional horses were infected by
the virus and were humanely killed. The first
death (of a mare) attributed to the infection occur-
red on 9 September 1994. The virus produced
severe damage to the lungs with the accumulation
of massive amounts of fluid. Two persons who
had close contact with the sick mare became
infected with the virus and also had respiratory
illness, in one case with fatal consequences.
During October 1995, a third human infection
with EMV was diagnosed. The infected man came
from a property in Mackay where two horses had
been diagnosed as dying from avocado poisoning
and snakebite during August 1994.
Rabies in Australia
On 24 May 1996, a black flying fox with signs
of neurologic illness was found in Ballina, New
South Wales, Australia, and was submitted for
autopsy. Histopathologic examination of the brain
showed severe nonsuppurative encephalitis. Tis-
sues were examined for EMV infection at the
Animal Research Institute, Brisbane. Additional
fixed tissues were sent for EMV and rabies
testing. Results were negative for EMV. How-
ever, immunoperoxidase testing on fixed brain
tissue was positive for Lyssavirus antigen and
was subsequently confirmed by immuno-
fluorescence testing. Subsequent investigations
have indicated that the Lyssavirus present is not
classic rabies, serotype 1. A range of cell cultures
and mice inoculations were carried out to
characterize the specific Lyssavirus involved.
Rabies in the United Kingdom
Since 30 May, four people in the vicinity of
Newhaven, on the south coast of England, were
thought to have been in contact with an insec-
tivorous bat with rabies. After the bat was caught
and humanely killed, on 3 June, the carcass was
examined, and the diagnosis of rabies was con-
firmed. In the past 30 years, three human deaths
have been associated with bat rabies in Europe,
one in Finland and two in the former Soviet
Union. Bat rabies is mainly confined to serotine
bats in Europe, particularly in Denmark,
northern Germany, and the Netherlands. Sero-
tine bats are relatively uncommon in the United
Kingdom. In the United States, four cases of
human rabies, caused by different variants of
rabies viruses associated with insectivorous
bats, were reported in 1995.
Reemerging Zoonoses
Venezuelan Equine Encephalitis in
Colombia and Venezuela
An outbreak of Venezuelan equine encepha-
litis (VEE), which began in early September
1995, was reported on the border between Colom-
bia and Venezuela. As of 21 September 1995, 825
human cases of VEE had been reported, with five
confirmed by laboratory analysis and four
resulting in death in Venezuela, mainly in the
state of Zulia. In Colombia, more than 450 cases
have been reported in the Department of La
Guajira. VEE is the most severe of several
viruses causing disease in horses and can be
transmitted to humans by mosquito bites. Most
infections are relatively mild, and symptoms
include abrupt onset of severe headache, chills,
fever, muscular pain, nausea, and vomiting.
Clinical cases occur in 11% to 20% of the
exposed population, and death occurs in fewer
than 1% of those cases. Large-scale epidemics of
VEE occurred in Colombia, Peru, Trinidad, and
Venezuela in the 1950s and Central America and
Mexico in the late 1960s, reaching the United
States (Texas) in 1971. Outbreaks can be pre-
vented by the regular immunization of horses in
the framework of public health programs.
Leptospirosis in Nicaragua
On 1 November 1995, health authorities in
Nicaragua established a task force to determine
the cause of an unidentified illness that affected
hundreds of residents of the Achuapa area,
causing some 15 deaths. A task force investigated
the nature and origins of the unknown disease,
whose symptoms ranged from high fever to
internal bleeding. On 6 November 1995, tests
conducted by the Centers for Disease Control and
Prevention (CDC), Atlanta, Georgia, USA,
indicated that the cause of the disease that killed
at least 16 people in Nicaragua was an unusual
form of leptospirosis. Initial reports that the
disease was dengue fever, which has been
common in the region, were ruled out after
several autopsies showed severe respiratory
hemorrhaging, and laboratory tests for dengue
fever proved negative. Tests on three of the four225 Vol. 3, No. 2, April–June 1997 Emerging Infectious Diseases
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specimens were positive for leptospirosis.
Leptospirosis, while not rare in the Americas or
Asia, usually affects the liver or kidneys, rather
than the respiratory system.
Enterohemorrhagic E. coli
Infection in Japan
An outbreak of enterohemorrhagic E. coli
(EHEC) infection among schoolchildren was
announced in Sakai City (population ca. 800,000),
in the region of Osaka, Japan, in July 1996. Most
of the reported cases were in children 6 to 12 years
of age from 62 public elementary schools of the
municipality. EHEC serotype O157 was detected
in patients’ stool samples. School lunch, which
was prepared in individual schools from the foods
delivered by a central supply station, was the
suspected cause of this outbreak; the responsible
food is still unknown. Epidemiologic investigation
has shown that fresh radish sprouts (kaiware-
daikon) were among the foods eaten by the
schoolchildren. However, samples of radish seeds
and sprouts, water, and soil from the environment
of the farm concerned and stool samples from the
farm workers showed no trace of this organism.
As of 26 August 1996, 9,578 cases of E. coli sero-
types O157:H7 and O157:H- infection, in both
outbreaks and sporadic infec-tions resulting in
11 deaths, had been reported in Japan. Although
most of the cases are believed to be foodborne, the
responsible foods have not been identified with
certainty except in a few isolated cases. Investi-
gations of outbreaks in other countries have estab-
lished that animals, especially cattle, are major
reservoirs of Shiga-like toxin producing E. coli
and that foods of bovine origin, such as ground
beef and unpasteurized milk, are the principal
sources of human infection. The possibility that
the source of the responsible agent is of animal
origin should be further investigated in Japan.
Potential Zoonoses
The natural cycle of Ebola is not known, and
its reservoir (i.e., the vertebrate playing an essen-
tial role in the maintenance of the agent and its
life cycle, if one exists) remains to be identified.
On the other hand, exposure to the agent of bovine
spongiform encephalopathy (BSE), a known disease of
cattle, is suspected to be the origin of a new
variant form of Creutzfeldt-Jakob disease (CJD)
in humans in the United Kingdom. These poten-
tial zoonoses have very recently had a considerable
impact on public health, animal production, and
laboratory animal sectors worldwide in view of the
need to minimize the risks for humans.
Bovine Spongiform Encephalopathy
BSE is a fatal disease of cattle that first came
to the attention of the scientific community in
November 1986 with the appearance in cattle of a
newly recognized form of neurologic disease in
the United Kingdom. Between November 1986
and 31 May 1996, approximately 160,000 cases of
this newly recognized cattle disease were con-
firmed on approximately 33,400 farms. The disease
is now on the decline in the United Kingdom.
Epidemiologic studies suggested that the source
of disease was cattle feed prepared from car-
casses of dead ruminants. Modifications to the
process used for preparing cattle feed introduced
in 1981 to 1982 may have been a risk factor by not
eliminating the agent from the feed. By May
1996, BSE had been reported from 10 countries
and areas outside the United Kingdom. In one
group of countries—France, Portugal, the Republic
of Ireland, and Switzerland—the disease occurred
in native cattle and could be linked to impor-
tation of potentially infected cattle feed from the
United Kingdom. In another group—the Falkland
Islands, Oman Sultanate, Germany, Canada,
Italy, and Denmark—cases were only identified
in cattle imported from the United Kingdom.
BSE is associated with a transmissible agent,
the nature of which is not yet fully understood,
and is one of several forms of transmissible brain
disease of animals. A number of similar severe and
fatal neurologic human diseases are due to non-
conventional agents. These diseases include
kuru, a disease that was transmitted by human
ritual handling of bodies and brains of the dead
and was identified in Papua, New Guinea in the
1950s, and the various forms (i.e., sporadic,
familial, and iatrogenic) of CJD, a rare disease
with a worldwide distribution.
After the identification of BSE, because the
above human and animal diseases shared a num-
ber of characteristics, including their ability to be
transmitted experimentally to a range of animals,
the World Health Organization (WHO) held, or
coorganized as a regular activity, four consul-
tations during 1991 to 1995 to study these diseases
(called transmissible spongiform encephalopathies).
An express purpose of these consultations was to
review the possible human public health
implications of animal spongiform encephalo-
pathies, with a special emphasis on BSE.226 Emerging Infectious Diseases Vol. 3, No. 2, April–June 1997
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The sudden announcement on 20 March 1996
by the United Kingdom of a cluster of 10 human
cases identified with what appears to be a variant
of CJD necessitated a fifth and sixth consultation
at WHO because the results of the investigation
indicated that, although there was no direct
evidence of a link, the most likely hypothesis was
that these cases might be related to exposure to
BSE in the United Kingdom. The fifth consul-
tation reassessed current recommendations in
light of these new developments and issued
recommendations to further minimize risks for
consumers particularly in relation to foods and
food products of animal origin. This was achieved
through the organization of expert consultations
first held in April 1996. The sixth consultation by
WHO was organized in May 1996 to propose to its
member states a protocol for global surveillance
of the new variant form of CJD and identify the
main areas for research on these diseases. Other
consultations may be held when new findings
with a bearing on public health become available.
Ebola and Ebola-related Viruses
In 1976, Ebola attracted worldwide attention
with the outbreaks of Yambuku, Zaire, with 318
cases and Nzara, Sudan, with 284 cases, charac-
terized by very high case-mortality rates (53% in
Sudan and 88% in Zaire). In the first cases at the
origin of the outbreaks (index cases) the patients
may have had contacts with infected animals or
their products (bats and/or rodents in Sudan, meat
from monkeys or wild antelopes in Zaire), but con-
tact could not be proven, and investigations of the
possible animal reservoir remained inconclusive.
During 1977 to 1989 a small number of sus-
pect, sporadic cases, or relatively small outbreaks
were reported (e.g., in Nzara, 1979). In 1989, a
new Ebola-related virus was isolated from
macaques originally captured in the wild in the
Philippines  dying from acute hemorrhagic fever
and imported into the United States. The same
virus, called Reston, was isolated again in dif-
ferent animal colonies in macaques imported
from the same country in 1990 (United States),
1992 (Italy), and 1996 (United States).
In 1994, 15 years after the last Ebola out-
break (Nzara, 1979) reported in Africa, a Swiss
ethologist became infected by a new Ebola variant
after doing a postmortem on a chimpanzee from
the Tai forest in Côte d’Ivoire. The infection was
demonstrated in this chimpanzee, and a number
of deaths reported in these animals in 1994 in the
Tai forest were associated with this agent. Other
outbreaks may have occurred in the chimpanzee
population of the Tai forest before 1994. In January
1995, a new Ebola epidemic was reported in
Kikwit, Zaire, with 315 cases and 244 deaths.
The initial source of the infection of this outbreak
may have been a forest worker involved in char-
coal making. A year later, in January 1996, an
outbreak occurred in Makokou, Gabon, with 37
cases and 21 deaths. The investigation of this out-
break showed that most patients had contacts with
dead chimpanzees that they butchered. In Octo-
ber 1996, a second outbreak was reported in the
Makokou region. The number of cases was 24
with 17 deaths on 12 November 1996. The index
case was a hunter who fell ill in July 1996 and died
in August in Booue hospital 200 km from Makokou.
Nothing definite is known on the reservoir of
Ebola virus. A number of hypotheses have been
proposed involving rodents or insects and even
viruses of plant origin. It is generally agreed that
the species of monkeys and apes in which the
virus stains have been isolated so far are only
victims of the disease, because in view of the high
mortality rates usually observed, these popu-
lations could not sustain themselves or the agent
for very long. These animals, however, participate
in virus amplification by facilitating further virus
transmission, including to humans, through
handling of monkey carcasses or consumption of
their meat. The identification of a new variant of
Ebola in chimpanzees in its natural environment
is a unique opportunity; so far the agent was only
isolated from monkeys captured in the wild but
(at time of the disease) located far from their
natural environment. WHO, in collaboration with
scientists from many countries including Switzer-
land, France, the United Kingdom, Sweden,
Canada, and the United States, has, therefore,
initiated a multidisciplinary study in the Tai
forest in Côte d’Ivoire to identify the natural
reservoir of the virus on the basis of the behavior
of the chimpanzees. This identification would be
essential to understanding the mechanisms for
transmission in nature and facilitating the pre-
vention of future Ebola outbreaks.
Xenografts and Xenozoonoses
Successful xenotransplantation (the transfer
of animal organs or tissues into human recipients)
may quickly become a biomedical reality. The
development of immunosuppressive drug proto-
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host disease, as well as advances in surgical
techniques is opening the door to a field that can
save thousands of human lives each year.
A risk of disease transmission is present in
any transplantation system. In allotransplan-
tation, disease transmission is a major cause of
illness and death in recipients. This is largely due
to the required level of recipient immunosup-
pression but is also attributable to infected, but
usually asymptomatic, human donors. Cases of
viral, bacterial, fungal, and parasitic transmission
are documented. In some cases, the presence of
the infectious agent was known before trans-
plantation. The decision was made to proceed
because of the lack of alternative donors. The
field of xenotransplantation also brings with it
the potential for introducing unwanted animal-
origin infectious agents, both known and as yet
unknown, into the human population. These
agents could cause disease in their new host.
Dissemination beyond the original recipient into
the general population could lead to epidemics.
Xenotransplantation, therefore, has the potential
for being both of great benefit and of detriment
to humans. WHO is developing guidelines to
ensure the development of xenotransplant
donors free of zoonotic and other agents repre-
senting a potential risk for the recipient.
Reasons for the Increasing
Trend–Control Measures
As shown in this paper, in both the
developing and industrialized worlds, a number
of zoonoses have emerged either as new patho-
logic entities or as already known agents,
appearing in areas or species where they had not
been previously reported or where they had
seemingly disappeared. The reasons for this
increasing trend are complex, but some have
been identified as follows: 1) alteration of the
environment affecting the size and distribution of
certain animal species, vectors, and transmitters
of infectious agents of humans; 2) increasing
human populations favoring an increased level of
contact between humans and infected/affected
animals; 3) industrialization of foods of animal
origin; changes in food processing and consumer
nutritional habits; and, 4) increasing movements
of people as well as trade of animals and animal
products and decreasing activities for the
surveillance and control of major zoonoses.
Although the prevalence of major zoonoses,
such as brucellosis, tuberculosis, and dog rabies,
has been greatly reduced in the industrialized
world, these diseases have not been eliminated
altogether; zoonoses prevention and control will
remain an area of major concern in most
developing countries. Recent observations show
that expenses related to the prevention of zoo-
notic diseases in humans are likely to increase
dramatically in these countries in the near future
if no programs for their control and elimination in
animal reservoirs are implemented. Diseases
such as brucellosis, rabies, and bovine tuberculosis
will certainly be brought under control during
the first decade of the second millennium, but
this will require constant efforts for the next 15 to
20 years. Also, as the trade of animal products
and the movements of people become more
intense, the risks of introduction/reintroduction
of certain diseases in a country increase. It is very
likely, in view of the foreseeable global changes
over the next few decades (e.g., population
growth, urbanization, and climatic changes),
that this trend will continue and even increase.
Human disease patterns will be affected by high
densities and movements of human populations
within and between countries and changes in
lifestyles; animal disease patterns will be
affected by changing land-use patterns, new
farming practices, displacement of animals, and
environmental contamination.
Infectious diseases, including zoonoses, will
remain the major health problems in most
developing countries, together with opportunistic
infections, including zoonotic diseases as a very
important component. In industrialized countries,
where cardiovascular diseases and cancers will
remain the main causes of illness and death in
spite of the AIDS pandemic, special attention will
need to be paid to human-animal relationships
especially with groups at higher risk such as the
elderly, who already represent a significant part
of the population of industrialized countries, as
well as children and childbearing women, HIV-
infected persons, and AIDS patients.
As zoonoses and animal diseases with the
potential to affect human health likely will con-
tinue to emerge and reemerge, zoonoses surveil-
lance will need to be reinforced and maintained
at the national and international levels. In view
of the foreseeable unplanned urbanization phe-
nomenon and the associated lack or shortage of
basic facilities, a strategy to respond to human
and animal health problems in an urban
environment will need to be developed for cities of228 Emerging Infectious Diseases Vol. 3, No. 2, April–June 1997
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both industrialized and developing countries.
Comprehensive plans will need to be developed to
reduce the rural-urban migration flow to reverse
the current and anticipated trend. Major compo-
nents of these plans should include improving
rural employment and food availability by pro-
moting animal production projects and improving
health through zoonoses control and reduction of
environmental pollution related to animal rearing.
Further collaboration is essential between all
professions involved in food technology develop-
ment, food industry control, and promotion of
new production techniques at the primary produc-
tion level in order to ensure food protection and
response to the needs of the world population.
F.-X. Meslin
Division of Emerging and Other Communicable
Diseases–Surveillance and Control,
World Health Organization, Geneva, Switzerland
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